1. Involvement of Bcl-XL deamidation in E1A-mediated cisplatin sensitization of ovarian cancer cells
- Author
-
E. I. T. Chen, H.-H. Hsu, Wei Ping Lee, Y.-M. Lin, and Chih-Hsien Chang
- Subjects
Cancer Research ,Programmed cell death ,viruses ,Phosphatase ,bcl-X Protein ,Antineoplastic Agents ,Apoptosis ,Caspase 3 ,Bcl-xL ,Biology ,Transfection ,Retinoblastoma Protein ,Tumor Cells, Cultured ,Genetics ,medicine ,Humans ,Deamidation ,Molecular Biology ,Ovarian Neoplasms ,Cisplatin ,Amides ,Caspase Inhibitors ,Molecular biology ,Biochemistry ,Caspases ,Mutagenesis, Site-Directed ,biology.protein ,Female ,Adenovirus E1A Proteins ,medicine.drug - Abstract
The adenovirus E1A protein has been shown to be involved in the potentiation of apoptosis induced by chemotherapeutic agents, yet the molecular events of E1A-mediated apoptosis are not very clear. A recent report has suggested that deamidation of the Bcl-X(L) protein inhibits its antiapoptotic ability and leads to apoptosis induced by alkylating agents in Rb-deficient tumor cells. Since Rb is known to interact with E1A, which interrupts Rb's normal function, we examined Bcl-X(L) deamidation and cell death induced by cisplatin in E1A transfectants. We found that the E1A transfectants became sensitive to cisplatin-induced apoptosis compared to the parental cells, SKOV3.ip1. Our data show that cisplatin treatment induced the modification of Bcl-X(L) in the E1A transfectants in dosage and time-dependent manner. Furthermore, phosphatase treatment had no effect on the level of Bcl-X(L) modification, whereas alkaline lysis buffer appeared to induce the same modification of Bcl-X(L). Ectopic expression of the deamidated forms of Bcl- X(L) in SKOV3.ip1 cells revealed that the modification to the Bcl- X(L) protein molecules was deamidation. Expression of the E1A mutant (dl1108) which contains deletion at CR2 domain suppressed Bcl-X(L) deamidation and apoptosis induced by cisplatin. We also found that expression of the nondeamidated Bcl-X(L) protected E1A transfectants from apoptosis. These findings suggest that Bcl-X(L) deamidation contributes to E1A-mediated cisplatin sensitization in SKOV3.ip1 cells.
- Published
- 2005